From: A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor
Placebo
(N = 3)
GSK3008348 1000 mcg
(N = 5)
Number of participants with any AE, n (%)
1 (33)
3 (60)
Diarrhoea
0
Urinary tract infection
1 (20)
Headache
Contact dermatitis
Tooth extraction